Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode
- 1 March 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (5) , 1543-1547
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemiaMolecular Cancer Therapeutics, 2009
- Pyrido[2,3-d]pyrimidin-5-ones: A Novel Class of Antiinflammatory Macrophage Colony-Stimulating Factor-1 Receptor InhibitorsJournal of Medicinal Chemistry, 2009
- Effects of the cFMS Kinase Inhibitor 5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in Normal and Arthritic RatsThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Structure-based optimization of a potent class of arylamide FMS inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitisJournal of Neuroimmunology, 2008
- Discovery of novel FMS kinase inhibitors as anti-inflammatory agentsBioorganic & Medicinal Chemistry Letters, 2008
- The orally‐active and selective c‐Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen‐induced arthritis mouse modelEuropean Journal of Immunology, 2007
- Potent 2′-aminoanilide inhibitors of cFMS as potential anti-inflammatory agentsBioorganic & Medicinal Chemistry Letters, 2007
- Inhibition of colony-stimulating-factor-1 signalingin vivowith the orally bioavailable cFMS kinase inhibitor GW2580Proceedings of the National Academy of Sciences, 2005
- CSF-1 regulation of the wandering macrophage: complexity in actionTrends in Cell Biology, 2004